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Of the factors governing human-to-human transmis-
sion of the highly pathogenic avian-adapted H5N1
virus, the most critical is the acquisition of mutations
on the viral hemagglutinin (HA) to ‘‘quantitatively
switch’’ its binding from avian to human glycan
receptors. Here, we describe a structural framework
that outlines a necessary set of H5 HA receptor-
binding site (RBS) features required for the H5 HA
to quantitatively switch its preference to human
receptors. We show here that the same RBS HA
mutations that lead to aerosol transmission of A/Viet-
nam/1203/04 and A/Indonesia/5/05 viruses, when
introduced in currently circulating H5N1, do not
lead to a quantitative switch in receptor preference.
We demonstrate that HAs from circulating clades
require as few as a single base pair mutation to quan-
titatively switch their binding to human receptors.
The mutations identified by this study can be used
to monitor the emergence of strains having human-
to-human transmission potential.
INTRODUCTION
The highly pathogenic H5N1 influenza A virus subtype poses a
global health concern. This is evident from it having already led
to several localized outbreaks in humans with a high case fatality
ratio (60%) since 2003 (Guan et al., 2009; Neumann et al.,
2010). The H5N1 subtype, however, has not yet adapted to the
human host and established sustained human-to-human trans-
mission via respiratory droplets (or aerosol transmission). One
of the key factors governing adaptation of virus to human host
is the glycan receptor-binding specificity of its hemagglutinin
(HA). The HA from avian subtypes typically binds to a2/3
sialylated glycans (or avian receptors) (Ge and Wang, 2011). A
hallmark feature of human-adapted subtypes such as H1N1,
H2N2, and H3N2 is the ‘‘quantitative switch’’ in their binding
preference to a2/6 sialylated glycan receptors (or humanreceptors), which is defined by high relative binding affinity to
human receptors over avian receptors. This quantitative switch
in receptor specificity has been shown to correlate with the res-
piratory droplet transmissibility of the pandemic H1N1 and H2N2
viruses in ferrets (Pappas et al., 2010; Srinivasan et al., 2008;
Tumpey et al., 2007; Viswanathan et al., 2010). A necessary
determinant of human adaptation of avian-adapted H5N1 sub-
type therefore is for its HA to acquire mutations that quantita-
tively switch its binding preference to human receptors (Ge
and Wang, 2011; Shriver et al., 2009). Structure and receptor
complexes of the HA from different subtypes (H1, H2, H3, and
H5) have shed light on the nature of mutations preferred by avian
and human viruses (Gamblin et al., 2004; Liu et al., 2009; Ha
et al., 2001; Lin et al., 2012). These studies showed that the res-
idues at 226 and 228 are critical determinants of the receptor-
binding specificity of H2 and H3 HA, with human viruses favoring
L226 and S228 and avian viruses favoring Q226 and G228 (Lin
et al., 2012; Liu et al., 2009). On the other hand, for H1 viruses,
190 and 225 are critical determinants of the receptor-binding
specificity, with human viruses favoring D190 and D225 and
avian viruses favoring E190 and G225 (Gamblin et al., 2004).
Identifying mutations that switch glycan receptor-binding prefer-
ence of H5 HA has been the focus of several previous studies
(Chandrasekaran et al., 2008; Gambaryan et al., 2006; Stevens
et al., 2006, 2008; Wang et al., 2009; Watanabe et al., 2012;
Yamada et al., 2006). Some of these studies include analyses
of glycan receptor binding of H5 HAs with natural variations in
the receptor-binding site (RBS) (Yamada et al., 2006). Other
studies have mutated H5 HA to include either the ‘‘hallmark’’
changes for human adaptation of H2/H3 HA (Q226L and
G228S or LS) and/or H1 HA (E190D, G225D, or DD). More
recently, two studies by Imai et al. (2012) and Herfst et al.
(2012) demonstrated that specific sets of mutations in HA
from A/Vietnam/1203/04 (Viet04) and A/Indonesia/5/05 (Ind05)
viruses, respectively, confer respiratory droplet viral transmis-
sion in ferrets to the viruses possessing these mutant H5 HAs.
From these studies, it is evident that differences in genetic back-
ground (using natural H5N1 isolate versus laboratory reassorted
strain) and selection pressure strategies give rise to distinct sets
of amino acid changes in Viet04 and Ind05 HAs that are associ-
ated with aerosol transmission in ferrets. None of the wild-typeCell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc. 1475
(WT) natural variants or mutant H5 HAs from the aforementioned
studies, however, have shown a quantitative switch in binding to
human receptor in a fashion characteristic of ‘‘pandemic’’ strain
HAs (such as 1918H1N1, 1958H2N2, and 2009H1N1) (Figure S1
available online).
Sequences of H5 HA isolated after 2006 have diverged
considerably from the prototypic strains Viet04 and Ind05. This
sequence divergence has critical implications for identifying
amino acid changes in the RBS required to quantitatively switch
the binding preference of H5 HA to human receptors. In this
scenario, an important unanswered question is how current H5
HA would quantitatively switch to human receptor binding in
the context of other molecular changes in its RBS due to
sequence divergence from prototypic strains such as Viet04
and Ind05 (Watanabe et al., 2011, 2012).
In this study, we have developed a distinct structural frame-
work to systematically analyze RBS of H5 HA from the perspec-
tive of structural topology of its glycan receptor, residues that
interact with this receptor, and their interresidue interactions in
the RBS. Using this framework, we compared the RBS of H5
HA with that H2 HA—its phylogenetically closest neighbor—to
define molecular features that are critical for quantitative switch-
ing H5HA binding to human receptors. Analysis of sequences for
naturally evolving H5 HAs show that the different H5 clades have
evolved to acquire distinct features that make them closer to
human adaptation. We demonstrate that a subset of rapidly
evolving and currently circulating H5 clades require as few as a
single base pair change to quantitatively switch to human recep-
tor binding. However, the acquisition of these distinct features in
the various clades appears to be somewhat nuanced. We show
here that amino acid changes that led to aerosol transmission of
Viet04 and Ind05, when introduced in the HA of some of the
currently circulating H5 clades, did not quantitatively switch
these H5 HA binding to human receptors. Our study highlights
the critical need to investigate RBS amino acid sequence diver-
gence of H5HA in the context of RBSmolecular features to delin-
eate H5N1 human adaptation.
RESULTS
Defining Molecular Features for H5 HA RBS
Webegan by systematically analyzing the RBS of H5HA from the
perspective of structural topology of its natural avian receptor
and that of the amino acids in the RBS. Previously, we had devel-
oped a framework to distinguish binding of HA to avian and
human receptors on the basis of the three-dimensional structural
topology of these receptors (Chandrasekaran et al., 2008). When
bound to HA, the avian receptor sampled a conformational
space that resembles a cone (thus the term cone-like topology
was used to describe this receptor). The majority of contacts
of H5 HA (using Viet04 crystal structure [Stevens et al., 2006,
2008]) with avian receptor adopting a cone-like topology involve
the Neu5Aca2/3Gal/motif. The key amino acids in the H5 HA
RBS involved in this interaction predominantly lie in the base
of the RBS, involving residues Ser-136 in 130 loop, Trp-153,
Ile-155 in the 150 loop, Lys-222, and Gln-226 in the 220 loop
with specific additional contacts from Glu-190, Lys-193, and
Leu-194 in the 190 helix at the top of the RBS (Figure 1).1476 Cell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc.There are several human-adapted HAs, including various
seasonal and pandemic strains from H1N1, H3N2, and the
pandemic H2N2 subtypes. Based on the phylogenetic ‘‘close-
ness’’ ofH5HA toH2HA (FigureS2),weselected human-adapted
H2N2 HA (A/Albany/6/58 or Alb58) bound to human receptor to
contrast with the structural model of H5HAbound to avian recep-
tor (Stevens et al., 2006, 2008). We chose Alb58 as a representa-
tive H2N2 strain because it is a prototypic pandemic strain, and
we have already extensively characterized its quantitative glycan
receptor binding and phenotypic properties (such as aerosol
transmissibility) (Pappas et al., 2010; Viswanathan et al., 2010).
As the X-ray crystal structure of Alb58 HA is not available, we
constructed a homology-based model for this HA using the
template crystal structure of another human-adapted H2 HA
(A/Singapore/1/57) (cocrystallized with human receptor), which
has high sequence identity to Alb58 HA (Liu et al., 2009).
The human receptor bound to HA samples a larger conforma-
tional space that resembles a fully closed to fully open umbrella
(and thus we have used the term umbrella-like topology to define
this receptor). There are two regions in the umbrella-like topology
of the human receptor: the base region composed of
Neu5Aca2/6Galb1/motif andan extension region comprising
sugar residues beyond this motif (typically GlcNAcb1/
3Galb1/). These two regions span a wider range of interacting
amino acids in the H2 HA RBS. A comparison of H5 HA bound
to avian receptor in cone-like topology and H2 HA bound to hu-
man receptor in umbrella-like topology showed four key differ-
ences (Figure 1). First, the composition of the 130 loop of H2 HA
is different from H5 HA in that there is a deletion in this loop (Fig-
ureS3). Thedeletion in the130 loop inH5HA relative toH2HAcrit-
ically influences the 130 loop. Second, amino acids in the ‘‘base’’
of the RBS (such as those in the 130 loop at positions 136–138
and the 220 loop at positions 219–228) are different. Third, the
‘‘top’’ of the RBS primarily comprising the ‘‘190 helix’’ (residues
188–196) that interactswith the extension region of human recep-
tor in H2 HA is different (specifically at positions 188, 189, 192,
and 193). Fourth, position 158 is glycosylated in H5 HA, but not
in H2 HA. Glycosylation at this site could potentially interfere
with theextension regionof human receptor (Stevenset al., 2008).
To determine what mutations are needed to overcome the
above differences and so that H5 HA can switch its specificity
to human receptor, we developed a metric (RBS network or
RBSN) to capture the network of interactions between the critical
residues in the RBS and other residues in their close spatial envi-
ronment that make contact with the glycan (see Experimental
Procedures). The higher the network score of an amino acid
within the RBS, the more structurally constrained it is to be
mutated. For example, residues that make critical contacts
with sialic acid such as Phe-98, Trp-153, and His-183 are highly
networked (RBSN scores > 0.7) and, hence, are less constrained
to mutate (Figure S4). On the other hand, residues that are at the
interface of the RBS and antigenic sites such as in the 130 loop,
190 helix, and 220 loop are poorly to moderately networked
(RBSN scores < 0.15) and can readily undergo mutations as a
part of antigenic drift. Thus, we define the term—molecular
feature (for each of the four differences)—that incorporates
glycan topology, HA residues involved in the binding, and their
interresidue interaction network in the RBS. We demonstrate
Figure 1. Comparing Molecular Features in the RBS of H5 and H2 HA
The RBS of H5 and its phylogenetically closest H2 HA is rendered as a cartoon. The key residues are labeled, and their side chains are shown in stick repre-
sentation. The human receptor and avian receptor are shown with carbon atoms colored in magenta and yellow, respectively, in the stick representation at 50%
transparency. The four key features are indicated based on coloring the carbon atom in different colors. The 130 loop (feature 1) is shown in cyan. The base of the
RBS (feature 2), including residue positions 136–138, 153, and 221–228, is shown in gray. The side chain of Arg in the 224 position is shown at 50% transparency.
The top of the RBS (feature 3), including the 190 helix and residue positions 155, 156, and 219, is shown in green. The glycosylation sequon at the 158 position
(feature 4) in H5 HA is shown in orange. The RBSN diagram is shown adjacent to the residue positions in that network. The circular nodes are colored according to
their RBSN score (pink representing a low score to bright red representing a high score) and their connectivity to other nodes. The asterisk next to residue
positions indicates that these positions belong to the adjacent HA1 domain in the HA trimer. The HA structure images were generated using Pymol (http://www.
pymol.org/).
See also Figures S2, S3, and S4.that such an approach provides a robust framework to investi-
gate amino acid mutations (and hence matching features) that
quantitatively switch binding of H5 HA to human receptors in a
manner similar to what has been observed for pandemic HAs.
Amino acid changes related to feature 1 involve altering the
length of the 130 loop specifically by introducing a deletion,
which, in turn, affects the RBSN diagram involving 131, 133,
and 155 positions. Residues at positions 131 and 133 had low
RBSN scores (<0.04) in H5 HA and therefore could be readily
mutated in context of the 130 loop deletion such that it contrib-
utes to human receptor specificity. Changing the base of the
RBS (feature 2), which plays a critical role in governing glycan
receptor specificity, involves alteration of a combination of resi-
due positions in the 130 loop and 220 loop. In H5 HA, Gln-226
plays a critical role in contacts with Neu5Aca2/3Gal/ motif
of avian receptor, and Ser-137 and Gln-226 are involved in the
interresidue interaction network. Conversely, in H2 HA, the cor-
responding Leu-226 and Arg-137 are not related. Arg-137 andSer-228 in H2 HA provide additional stabilizing contacts with
sialic acid. Therefore, one way to match feature 2 (for human re-
ceptor binding) involves changing residues at 137 and 226 posi-
tions in H5 HA. Residue position at 137 is readily mutable given
its low RBSN score in H2 and H5 HA (0.01). However, residue
at 226 has a much higher RBSN score in H2 and H5 HA (>0.25).
Making changes to this residue therefore would also involve
making other changes—specifically, changing Gly-228/Ser in
addition to Ser-137/Arg mutation. Although Gln-226/Leu
mutation governs switch in contacts from Neu5Aca2/3Gal/
to Neu5Aca2/6Gal/ motif, Ser-137/Arg and Gly-228/Ser
mutation provides additional stabilization to the 130 and 220
loop at the base of the H5 RBS from the standpoint of interamino
acid networking and improved contacts with glycan receptor
(Stevens et al., 2006, 2008). This stabilization can also be
accomplished by mutation Asn-224 to Lys or Arg (naturally
observed in some pandemics), as this would enhance its intera-
mino acid interaction network with Asp-96, Leu-97, and Pro-99Cell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc. 1477
(legend on next page)
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(Figure 1). Therefore, feature 2 can also be matched by fewer
mutations at 224 and 226 positions. The RBSN diagram of the
residue at the 221 position in H5 HA is identical to that in H2
HA, although this position has a Ser in H5 HA and a Pro in H2
HA (Figure 1). It is likely for the Pro to govern the conformation
and side-chain orientation of the adjacent Lys-222 residue,
which plays a key role in making contacts with the human recep-
tor. Therefore, changing Ser-221/Pro in H5 HA would permit
more optimal conformation of the 220 loop for contact with the
human receptor. On the other hand, mutations at positions
188, 189, 192, and 193 and the RBSN diagrams depicting their
interaction networks (Figure 1) will impact feature 3. The residues
Ala-188, Ala-189, and Thr-192 in H5 HA do not have any interre-
sidue contacts with other residues in the RBS. However, resi-
dues Glu-188, Thr-189, and Arg-192 are involved in multiple
interaction networks. Therefore, amino acid changes in positions
188, 189, 192, and 193 (hence altering feature 3) of H5 HA RBS
would also impinge on its human receptor-binding property.
Given that the RBSN scores of all these residue positions are
low (<0.1) in H5 HA, they are readily mutable. Finally, removal
of glycosylation sequon at position 158 relates to feature 4.
This could be accomplished by mutating Asn-158 to a residue
such as Asp or by mutating Thr-160 to Ala.
Among these four distinct features, feature 2 critically influ-
ences the base of the RBS, which plays an important role in
distinguishing contacts between H5 and Neu5Aca2/3Gal/
motif (avian receptor) and H2 HA and Neu5Aca2/6Gal/motif
(human receptor). The difference in the 130 loop length (feature 1)
would potentially affect the base of the RBS, which, in turn, is
critical for glycan-receptor specificity. Changes related to
feature 2 to achieve the necessary glycan receptor specificity
therefore would critically depend on the 130 loop length
(feature 1). Conversely, feature 3, which involves the 190 helix,
plays an important role in contacts with avian receptor in H5
(specifically Lys or Arg at 193 position) and in contacts with
extension region of human receptor. Therefore, amino acid
changes in H5 HA related to feature 3 would reduce binding to
avian receptor and enhance contact with extension region of
human receptor. Feature 4 relates to the state of glycosylation
at position 158, which impinges on the interaction with the exten-
sion region of human receptor (Stevens et al., 2008).
Analyzing Natural Sequence Evolution of H5 HA from
the Perspective of RBS Features
Having described and contrasted the H5 HA RBS features
(henceforth referred to as RBS features) in the context of H2
HA RBS, we then investigated the acquisition of these features
in the context of sequence evolution of H5 HA over time instead
of searching for specific hallmark human-adaptive mutations
described in previous studies (Maines et al., 2011; NeumannFigure 2. Phylogenetic Tree of Representative A/H5N1HA1Protein Seq
The sequences are color coded by the features observed in the HA1 domain. Sca
in clade-2.2, -2.2.1, and -7 strains after 2006, whereas feature 2 has evolved in c
Some of the currently circulating clades (1, 2.1.3, 2.2, 2.2.1, 2.3.2, 2.3.4, and 7) ha
closer to human adaptation. Among these H5HAs, the relative order of dominant c
-2.2, -1, and -7. A subset of clade 2.2.1 and clade 7 has acquired amino acid ch
See also Table S1 and Figure S3.et al., 2012; Russell et al., 2012; Stevens et al., 2008). A phylog-
eny map of A/H5N1 HA1 sequences was constructed, and the
branches were color-coded based on the features present (Fig-
ure 2). Feature 4 has been observed in almost all of the clades;
however, amino acid changes characteristic of features 1, 2,
and 3 were observed more recently. Many of the clades,
including currently circulating clade 1, clade 2.2, clade 2.2.1,
and clade 7, have acquired amino acid changes characteristic
of one or two of features 1, 3, and 4. However, only a subset of
the rapidly evolving and currently circulating clades 2.2.1 and 7
have acquired amino acid changes— which are critical features
of the RBS base—to match feature 1 and/or part of feature 2. In
the context of the key structural features of HA RBS, the deletion
in the 130 loop with a concurrent loss of glycosylation (features 1
and 4) in the same HA was the most critical change observed in
the evolution of 2.2.1 H5 HA since 2007. A recent study (Russell
et al., 2012) compared the sequence evolution of H5N1 simply in
the context of hallmark changes reported by the twoH5N1 trans-
mission studies involving Viet04 (Imai et al., 2012) and Ind05
(Herfst et al., 2012) and indicated that clade 2.2.1 viruses were
most similar to human-transmissible virus. In this earlier analysis,
clade 7 does not appear to be significant. On the other hand,
apart from a subset of clade 2.2.1 strains that have acquired
one or more RBS features, many clade 2.2.1 strains have not
yet acquired any of the RBS features, hence they are almost
indistinguishable from noncirculating clades (3, 5, 6, 8, and 9).
Taken together, the above findings suggest that acquisition of
these distinct features in the various clades appears to be some-
what nuanced and that subsets of the currently circulating H5HA
strains have not only diverged considerably from older human
isolates (such as Viet04) but have also acquired the key molec-
ular RBS features necessary for human receptor preference.
Design and Validation of Amino Acid Changes Required
to Quantitatively Switch Receptor Specificity of
Currently Circulating H5 HA
Based on our analyses of the rapidly evolving and currently
circulating H5 HAs, we chose representative examples from a
subset of clades 2.2.1 and 7, which have already acquired amino
acid changes to match one or two of the RBS features, to vali-
date the framework and predictions. We chose A/chicken/Viet-
nam/NCVD-093/08 (ckViet08; clade 7 HA that acquired changes
in feature 3), A/Egypt/N03450/2009 (Egy09; clade 2.2.1 HA that
acquired changes in features 1 and 4), and A/duck/Egypt/
10185SS/2010 (dkEgy10; another clade 2.2.1 HA that acquired
changes in features 1, 4, and part of feature 2 based on
Asn224/Lys natural mutation). On these HAs from these
distinct recent H5 isolates, we introduced amino acid changes
to match one or more of the remaining features. We recombi-
nantly expressed WT and mutant forms of these HAs anduences Showing Clustering of Sequences Based onAntigenic Clades
le bar represents 0.001 amino acid substitutions per site. Feature 1 has evolved
lade-1 and -2.2.1 after 2007. Feature 3 has evolved in clade-2.2 and -7 strains.
ve acquired mutations to match multiple RBS features and hence appear to be
irculating clades found to have acquiredmultiple features includes clade-2.2.1,
anges in the RBS base toward matching feature 1 and/or feature 2.
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Table 1. Summary of RBS Features and Glycan-Binding Properties of WT and Mutant H5 HAs
Human Receptor/
Base (Neu5Aca2/6Galb1/) Extension (/4GlcNAcb1/3Galb1/4/) Glycan-Binding Specificity
F1 (D130 loop) F2 (RBS base) F3 (190 helix) F4 (no 158 glyco) a2/3 a2/6
ckViet08 (V4.0) K192/M193 +++ +
V4.2 Q226L/G228S K192/M193 T160A ++ ++
V4.3 N224K/Q226L K192/M193 T160A
V4.4 L133D N224K/Q226L K192/M193 N158D + +++
Egy09 (E4.0) D133 A160 +++
E4.3 D133 N224K/Q226L A160 + +++
dkEgy10 (E5.0) D133 K224 D158/A160 ++
E5.1 D133 K224/Q226L D158/A160 +++
The key amino acids inWTH5 that contribute to acquisition of the corresponding feature are indicated byWTamino acid (one letter code) followed by the
HAposition, whereasmutations introduced tomatch the features are indicated byWTamino acid followed by theHAposition and themutant amino acid.
Theblank feature columns indicate absence ofH2-likeRBS feature in theH5HAs. The apparent avian and human receptor-binding affinities are indicated
in the a2/3 and a2/6 columns in which highest = ++++, high = +++, moderate = ++, and low = +, and no observable binding = blank column.
See also Table S1.evaluated their glycan-binding properties in dose-dependent
direct glycan array assay. A summary of WT and mutant HAs
with their corresponding RBS features and glycan-binding prop-
erties is shown in Table 1. The details of the amino acid changes
to match RBS features are summarized in Table 1. The dose-
dependent glycan array data for the WT and mutant H5 HAs
are shown in Figure 3.
From Table 1 and Figure 3, it is evident that avian receptor
binding of WT H5 HAs that have already acquired one or more
of the RBS features is not as high as (specifically binding to 30
sialyl-lactosamine (SLN) what we have observed for other
avian-adapted HAs (Chandrasekaran et al., 2008; Viswanathan
et al., 2010). In the case of ckViet08 (Figure 3A), the natural
acquisition of changes in the 190 helix (feature 3), especially
Met-193, is consistent with lowering of avian receptor binding
because Lys or Arg at 193 in other H5 HAs (which have not
acquired feature 3) make optimal contact with the avian recep-
tors. In the cases of Egy09 and dkEgy10 (Figures 3C and 3E),
the 130 loop deletion (feature 1) does appear to also have
some detrimental effects on avian receptor binding.
We next sought to understand the relationship between
molecular features in recent H5 HAs and the hallmark amino
acid changes in Viet04 and Ind05 HA that conferred respiratory
droplet transmission to viruses having these mutant HAs (Herfst
et al., 2012; Imai et al., 2012). The LSmutation and loss of glyco-
sylation sequon at the 158 position were the RBS mutations
previously reported for Ind05 (Herfst et al., 2012). The LS amino
acid mutations only partially matched RBS base feature 2. Intro-
ducing the LSmutation with loss of 158 glycosylation sequon on
ckViet08 (V4.2) showed some increased human receptor binding
while retaining most of the avian receptor binding and, therefore,
did not quantitatively switch this mutant HA binding to human
receptors. Introducing the 130 loop deletion and amino acid
changes in addition to LS and loss of glycosylation at 158 (see
V4.5 in Table S1) completely switched binding to the human
receptor. Therefore, the LS mutation alone is not sufficient to
completely match (feature 2). The Asn-224/Lys/Gln226/Leu
and loss of the 158-glycosylation sequon were the RBS muta-
tions previously reported for Viet04 (Imai et al., 2012). As an1480 Cell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc.example, introducing these mutations on ckViet08 (V4.3) wholly
abolished binding to both avian and human receptors. However,
introducing the deletion in the 130 loop of V4.3 resulted in a
mutant (V4.4) that quantitatively switched binding to human
receptors (Figure 3B) (apparent binding affinity constant [Kd0]
for 60 SLN-LN 100 pM), highlighting the critical importance of
the RBS base (feature 2) and the 130 loop deletion (feature 1)
in modulating human receptor-binding specificity. Jointly, these
results clearly demonstrate that the same amino acid mutations
that led to aerosol transmission of Viet04 and Ind05 are not suf-
ficient to quantitatively switch current circulating H5 HA binding
to human receptors.
Egy09 already acquired amino acid changes tomatch features
1 and 4. Similar towhat was observedwith ckViet08 V4.2mutant,
introducing the LSmutations in the RBS base (partially matches
feature 2) even with the 130 loop deletion in Egy09 (E4.1) did not
quantitatively switch its binding to human receptor. Instead,
matching feature 2 by introducing the Asn-224/Lys/Gln-
226/Leu mutations on Egy09 (E4.3) quantitatively switched
its binding to the human receptor (Kd0 50 pM) (Figures 3C
and 3D). The dkEgy10 is one of a kind because it has evolved
to be the closest matching RBS features 1, 2, and 4. The glycan
receptor binding of dkEgy10 HA (Figure 3E) shows that the WT
HA still predominantly binds to avian receptors (30 SLN-LN and
30 SLN-LN-LN with minimal binding to 30 SLN and human recep-
tors). The predominant avian receptor-binding property of
dkEgy10 can be attributed to the 226 position, which still has a
Gln (and not Leu) that is needed to match feature 2. In fact, intro-
ducing this single Gln226/Leu amino acid mutation (which
involves a single base pair mutation) on dkEgy10 (E5.1) quantita-
tively switched its binding to human receptors (Kd0 100 pM)
(Figure 3F). The above mutant H5 HAs that show a switch in
receptor preference demonstrate the necessary apparent bind-
ing affinity to human receptor (similar to the 2009 H1N1
pandemic HA) and hence pass the threshold for potential aerosol
viral transmission (Figure S1).
To extend the quantitative characterization of glycan receptor
specificity to binding to physiological glycan receptors in human
respiratory tissues, we analyzed the binding of dkEgy10 WT and
Figure 3. Glycan Receptor Binding of WT and Mutant of H5 HAs HA
(A–F) Dose-dependent direct binding ofWT ckViet08, Egy09, and dkEgy10 is shown in (A), (C), and (E), respectively, and that of the V4.4, E4.3, andE5.1mutants is
shown in (B), (D), and (F), respectively. See also Tables 1 and S1 for descriptions of the mutants. Error bars were calculated based on normalized binding signals
for glycan array assays done in triplicate for each HA sample.
See also Figures S1 and S5.E5.1 mutant on human tracheal and alveolar tissues. Studies
previously have demonstrated that the apical surface of human
tracheal tissue predominantly expresses human receptors, and
the human alveolar tissue predominantly expresses avian recep-
tors (Chandrasekaran et al., 2008; Mansfield, 2007; Matrosovich
et al., 2004; Shinya et al., 2006). Consistent with the quantitative
switch to human receptor binding, E5.1 mutant showed the
expected staining of the apical surface of the human tracheal
tissue section, whereas the WT dkEgy10 showed extensive
staining of the human alveolar section (Figure 4A).
The above results together underscore the importance of
delineating key structural RBS features in H5 in conferring the
quantitative switch in binding to human receptors (Figure 4B).
The base of the RBS captured by feature 2, which plays a critical
role by making contacts with the terminal sialic acid linkage,
appears to be a key determinant. Our data show (and are consis-
tent with RBSN) that a combination of two amino acid changes,
Asn-224/Lys and Gln-226/Leu in the RBS base, is able to
match feature 2 effectively in specific H5 clades when compared
to the LS combination in which additional mutations match the
same feature. Our results also support a critical role for the
‘‘130 loop length’’ in augmenting the RBS base for optimal con-
tacts with the human receptor because changes to the RBS base
alone with Asn-224/Lys/Gln-226/Leu completely abolished
binding of ckViet08 V4.3 mutant. Many strains in the H5 clade
2.2.1 do not possess the ‘‘130 loop’’ deletion (feature 1). In these
strains, matching the critical feature 2, with feature 4 already
matched, does not confer a switch in H5 receptor specificity. A
representative clade 2.2.1 example (A/Egypt/2786-NAMRu3/06[Egy06] and its mutant [E3.1]) is shown in Table S1. These strains
are further away from human adaptation, and it cannot be gener-
alized, therefore, that all clade 2.2.1 strains are closest to human
adaptation. The 130 loop deletion has been naturally acquired by
a subset of clade 2.2.1 HA and shows a lowering in binding to
avian receptors as observed in both Egy09 and dkEgy10 strains.
Our structural analysis and data also indicate that involvement of
features 3 and 4—which impact contacts with the extension
region of the human receptor—in human receptor switch
depends on clade-specific H5 HA RBS. Consequently, in the
context of the current HA sequence evolution of rapidly evolving
H5N1, features 1 and 2 appear to be necessary and additionally
appear to be sufficient to match either feature 3 or 4 for human
adaptation of distinct H5 HA clades.
DISCUSSION
In summary, we have developed a distinct approach to define
the molecular features that characterize RBS of HA and have
used these features to compare RBS of H5 HA with that of its
closest phylogenetic neighbor—pandemic H2 HA. This network
approach permits us to understand how amino acid changes
(resulting from the extensive sequence divergence of H5 HA as
a part of its natural evolution) in the RBS modulate glycan-bind-
ing specificity. Using this approach, we demonstrate that some
of the recent H5 HAs require as few as one or two amino acid
mutations to quantitatively switch their receptor preference.
Importantly, our approach permitted us to scan the RBS of
HAs from various H5 isolates from 2007 for the naturalCell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc. 1481
Figure 4. Physiological Glycan Receptor
Binding and Summary of RBS Features in
Current H5 HAs
(A and B) In (A), the left panel shows staining of
human alveolar section by dkEgy10. The middle
panel shows staining of human tracheal tissue
section by the E5.1mutant. The right panel shows
staining of human tracheal tissue section by CA04.
For all the tissue sections, the HA staining is shown
in green against propidium iodide shown in red.
Apical surface of trachea is indicated by a white
arrow (B). Surface rendering of H5 RBS with the
region corresponding to features 1–4 is colored
cyan, gray, green, and orange, in that order. The
human receptor is shown as a stick. Features 1
and 2 are colored dark red to indicate their
necessary requirement for human adaptation of
H5 HA in the context of its current sequence
evolution.
See also Table S1 and Figure S3.acquisition of necessary RBS features for switch in receptor
specificity. Different phylogenetic clades of H5 have important
nuances to their RBS structural features, which, in specific in-
stances, dynamically change with the natural sequence evolu-
tion. Some features that are present in the parent clade might
be lost as this clade diversifies, or this diversification could
lead to the addition of features that are critical for human adap-
tation of H5 HA. Even within a clade, not all sequences have an
identical set of structural features. For example, in the case of
2.2.1 HAs, only 87% have loss of 158 glycosylation. Also, not
all 2.2.1 HAs have a deletion in the 130 loop. Data show that
the same amino acid mutations that lead to aerosol transmission
of Viet04 and Ind05, when introduced in more recent H5 HA, give
distinct results (depending on the H5 clade) and, importantly, do
not quantitatively switch any of themutant HAs binding to human
receptors. These residues alone cannot be used as reference
points to analyze the switch in receptor specificity of currently
circulating and evolving H5N1 strains (Russell et al., 2012).
A question arises as to the relationship between RBS of H5
and H1 HA—its second-nearest human-adapted phylogenetic
neighbor in group 1HAs (Figure S2).We have performed a similar
structural analysis and have demonstrated that amino acid1482 Cell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc.changes in H5 HA to match features
with RBS of pandemic H1N1 (A/South
Carolina/1/18) HA led to a quantitative
switch in binding to human receptors
(Figure S5). However, the current natural
evolution of H5 HA has led to acquisition
of RBS features along an H2-like path.
Human adaptation of H5 HA is one of
the key factors involved in the adaptation
of the H5N1 virus to the human host for a
sustained circulation. Other hallmark
factors and genetic signatures such as
Glu627/Lys in PB2, PB1-F2 length,
activity, and stalk length of neuramini-
dase have been associated withincreased pathogenicity and efficient transmission in humans
and ferret animal models. However, it is unclear as to how
many of these additional hallmark factors are required for the
human adaptation of this subtype. Nevertheless, from a surveil-
lance standpoint, it is critical to investigate amino acid sequence
divergence of H5 HA in the context of RBS molecular features in
addition to monitoring changes in other viral genes to delineate
H5N1 human adaptation.
EXPERIMENTAL PROCEDURES
Cloning, Baculovirus Synthesis, and Mammalian Expression
and Purification of HA
H5WT andmutant HA sequenceswere codon optimized for insect cell expres-
sion andwere synthesized at DNA2.0 (Menlo Park, CA). The synthesized genes
were then subcloned into pAcGP67A plasmid, and baculoviruseswere created
using Baculogold system (BD Biosciences, San Jose, CA) according to the
manufacturer’s instructions. The recombinant baculoviruses were then used
to infect suspension cultures of Sf9 cells cultured in BD Baculogold Max-XP
SFM (BD Biosciences, San Jose, CA). The infection was monitored, and the
conditioned media were harvested 3–4 days postinfection. The soluble HA
from the harvested conditioned media was purified using Nickel affinity chro-
matography (HisTrap HP columns, GE Healthcare, Piscataway, NJ). Eluting
fractions containing HA were pooled, concentrated, and buffer exchanged
into 13 PBS pH 8.0 (GIBCO) using 100 kDa MWCO spin columns (Millipore,
Billerica, MA). The purified protein was quantified using BCA method (Pierce).
The gene was codon optimized for mammalian expression, synthesized
(DNA2.0, Menlo Park, CA), and subcloned into modified pcDNA3.3 vector
for expression under CMV promoter. Recombinant expression of HA was car-
ried out in HEK293-F FreeStyle suspension cells (Invitrogen, Carlsbad, CA)
cultured in 293-F FreeStyle Expression Medium (Invitrogen, Carlsbad, CA)
maintained at 37C, 80% humidity, and 8% CO2. Cells were transfected
with Poly-ethylene-imine Max (PEI-MAX, PolySciences, Warrington, PA) with
the HA plasmid and were harvested 7 days postinfection. The supernatant
was collected by centrifugation, filtered through a 0.45 mm filter system
(Nalgene, Rochester, NY), and supplemented with 1:1,000 diluted protease
inhibitor cocktail (Calbiochemfiltration) and supplementedwith 1:1,000 diluted
protease inhibitor cocktail (EMD Millipore, Billerica, MA). HA was purified from
the supernatant using His-trap columns (GE Healthcare) on an AKTA Purifier
FPLC system. Eluting fractions containing HA were pooled, concentrated,
and buffer exchanged into 13 PBS pH 7.4 using 100 kDaMWCO spin columns
(Millipore, Billerica, MA). The purified protein was quantified using BCA
method (Pierce, Rockford, IL).
Both expression systems were used in this study. Importantly, no differ-
ences were observed in the glycan-binding properties of the HA derived
from baculovirus when compared to that of the material derived frommamma-
lian expression.
Homology Modeling of HA
A structural model of Alb58 HA trimer was built using the MODELER homology
modeling software. To build the model, the solved crystal structure of
A/Singapore/1/57 hemagglutinin with human receptor (PDB: 2WR7), which
has 99% sequence identity in HA1 to Alb58, was used as a template. During
modeling, the ligand (human receptor) was copied from the template structure
into the model structure. The final model was minimized to release internal
constraints.
Dose-Dependent Direct Binding of WT and Mutant HA
To investigate themultivalent HA-glycan interactions, a streptavidin plate array
comprising representative biotinylated a2/3 and a2/6 sialylated glycans
was used. 30 SLN, 30 SLN-LN, and 30S LN-LN-LN are representative avian
receptors. 60 SLN and 60 SLN-LN are representative human receptors. LN
corresponds to lactosamine (Galb1/4GlcNAc), and 30 SLN and 60 SLN,
respectively, correspond to Neu5Aca2/3 and Neu5Aca2/6 linked to LN.
The biotinylated glycans were obtained from the Consortium of Functional Gly-
comics through the resource request program. We have chosen a defined set
of representative avian and human receptors given that the focus of our exper-
imental studies is to quantitatively characterize relative binding affinity to
human versus avian receptors and not to define specificity on the basis of
number of human versus avian receptors using a larger array of glycans. The
quantitative affinity defined using our defined glycan array platform has been
used in several previous studies to correlate glycan-binding properties of HA
with physiological properties of the virus such as respiratory droplet transmis-
sion in ferrets (Jayaraman et al., 2011; Maines et al., 2009; Pearce et al., 2012)
and antibody response in mice (Hensley et al., 2009). Streptavidin-coated
high-binding-capacity 384-well plates (Pierce) were loaded to the full capacity
of each well by incubating the well with 50 ml of 2.4 mM of biotinylated glycans
overnight at 4C. Excess glycans were removed through extensive washing
with PBS. The trimeric HA unit is composed of three HAmonomers. The spatial
arrangement of the glycans in the plate array favors binding to only one of the
three HA monomers in the trimeric HA unit. Therefore, in order to specifically
enhance the multivalency in the HA-glycan interactions, the recombinant HA
proteins were precomplexed with the primary and secondary antibodies in
the molar ratio of 4:2:1 (HA:primary:secondary). The identical arrangement
of four trimeric HA units in the precomplex for all the HAs permits comparison
between their glycan binding affinities. A stock solution containing appropriate
amounts of histidine-tagged HA protein, primary antibody (Mouse anti-63 His
tag IgG from Abcam), and secondary antibody (HRP conjugated goat anti-
mouse IgG from Santacruz Biotechnology) in the ratio 4:2:1 was incubated
on ice for 20 min. Appropriate amounts of precomplexed stock HA were
diluted to 250 ml with 1% BSA in PBS. 50 ml of this precomplexed HA wasadded to each of the glycan-coated wells and incubated at room temperature
(RT) for 3 hr followed by the wash steps with PBS and PBST (13 PBS + 0.05%
Tween-20). The binding signal was determined based on HRP activity using
Amplex Red Peroxidase Assay Kit (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions. The experiments were done in triplicate. Min-
imal binding signals were observed in the negative controls, including binding
of precomplexed unit to wells without glycans and binding of the antibodies
alone to the wells with glycans. The binding parameters, cooperativity (n),
and Kd0 for HA-glycan binding were calculated by fitting the average binding
signal value (from the triplicate analysis) and the HA concentration to the line-
arized form of the Hill equation:
log

y
1 y

= n  logð½HAÞ  logK0d
where y is the fractional saturation (average binding signal/maximum observed
binding signal). In order to compare Kd0 values, the values reported in this
study correspond to the appropriate representative avian (30 SLN-LN or 30
SLN-LN-LN) and human (60 SLN-LN) receptors that gave the best fit to the
above equation and the same slope value (n value is 1.3).
As noted above, there were no differences in the glycan-binding properties
for HA derived from baculovirus when compared to that of HA produced via
mammalian expression.
Binding of WT and Mutant HAs to Human Tissue Sections
Paraffinized human tracheal and alveolar (US BioChain) tissue sections were
deparaffinized, rehydrated, and incubated with 1% BSA in PBS for 30 min to
prevent nonspecific binding. HA was precomplexed with primary antibody
(mouse anti-63 His tag, Abcam) and secondary antibody (Alexa Fluor 488
goat anti-mouse, Invitrogen) in a molar ratio of 4:2:1, respectively, for 20 min
on ice. The tissue binding was performed over two different HA concentrations
(40 mg/ml and 20 mg/ml) by diluting the precomplexed stock HA in 1% BSA-
PBS. Tissue sections were then incubated with the HA-antibody complexes
for 3 hr at RT. The tissue sections were counterstained by propidium iodide
(Invitrogen; 1,100 in TBST). The tissue sections weremounted and then viewed
under a confocal microscope (Zeiss LSM 700 laser scanning confocal micro-
scopy). Sialic-acid-specific binding of HAs to tissue sections was confirmed
by loss of staining after pretreatment with Sialidase A (recombinant from
Arthrobacter ureafaciens, Prozyme). This enzyme has been demonstrated to
cleave the terminal Neu5Ac from both Neu5Aca2/3Gal and Neu5Aca2/
6Gal motifs. In the case of sialidase pretreatment, tissue sections were incu-
bated with 0.2 units of Sialidase A for 3 hr at 37C prior to incubation with
the proteins. Pretreatment of human tracheal and alveolar tissue sections
with Sialidase A resulted in complete loss of HA staining.
Capturing Network of RBS Residues
The coordinates of the H5 HA-avian receptor and Alb58 HA-human receptor
complex were uploaded into the PDBePISA server (http://www.ebi.ac.uk/
msd-srv/prot_int/pistart.html) to determine key residues in the HA RBS that
make contact with the corresponding glycan receptor (interface cutoff of
30% was used). For these residues, their environment was defined using a
distance threshold of 7 A˚, and the contacts, including putative hydrogen
bonds (which include water-bridged ones), disulfide bonds, pi bonds, polar
interactions, salt bridges, and Van der Waals interactions (nonhydrogen),
occurring between pairs of residues within this threshold distance were
computed as described previously (Soundararajan et al., 2011). These data
were assembled into an array of eight atomic interaction matrices. A
weighted sum of the eight atomic interaction matrices was then computed
to produce a single matrix that accounts for the strength of atomic interaction
between residue pairs within the RBS, using weights derived from relative
atomic interaction energies (Soundararajan et al., 2011). The interresidue
interaction network calculated in this fashion generates a matrix that
describes all the contacts made by critical RBS residues with spatial proximal
neighboring residues in their environment. For each element i, j is the sum of
the path scores of all paths between residues i and j. The degree of
networking score for each residue was computed by summing across the
rows of the matrix, which was meant to correspond to the extent of
‘‘networking’’ for each residue. The interactional relationship between criticalCell 153, 1475–1485, June 20, 2013 ª2013 Elsevier Inc. 1483
RBS residues and their environment is represented using a two-dimensional
open connectivity network diagram (RBSN diagram). The degree of
networking score was normalized (RBSN score) with the maximum score
for each protein so that the scores varied from 0 (absence of any network)
to 1 (most networked). Although previous studies (Herfst et al., 2012; Imai
et al., 2012) have reported mutations in stalk and other regions of HA outside
the RBS, the RBSN does not include these residue positions, and hence, any
amino acid changes in these positions would not affect the glycan receptor-
binding property of HA.
Sequence Analysis of H5 HA and Estimation of Key Features
A total of 6,014 H5 HA sequences were downloaded from the EpiFlu database.
From this, only those sequences that had complete coding regions, including
start and stop codons, were considered. In order to avoid estimation errors
due to multiply represented sequences, all groups of identical sequences in
the data set were represented by the oldest sequence in the group. The
remaining 2,959 sequences were ordered by isolation time and aligned, and
the occurrence rate of each feature (defined as the percent fraction of
sequences from a given year that contains that feature) was calculated.
Phylogeny Tree Construction and Calculation of Sequence-Based
Distance Measure for RBS Analysis
Phylogeny tree was constructed for 2,959 H5 HA amino acid sequences
by neighbor-joining method using MEGA 5.10 software (http://www.
megasoftware.net/). The branches were colored based on the different fea-
tures present (Table 1) using the Rainbow Tree software (http://www.hiv.lanl.
gov/content/sequence/RAINBOWTREE/rainbowtree.html).
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